Tatva Chintan Pharma Chem posts Q1 FY24 consolidated PAT at Rs. 9.50 Cr
The company has reported total income of Rs. 115.37 crores during the period ended June 30, 2023
The company has reported total income of Rs. 115.37 crores during the period ended June 30, 2023
Aiming to establish a state-of-the-art healthcare facility in India that integrates the latest technologies, exceptional patient comfort, and optimal clinical outcomes
Aims to foster a Resilient and Sustainable Healthcare Ecosystem
More than 9600 Pradhan Mantri Bhartiya Janaushadhi Kendras have been set up covering all districts of the country to promote generic medicines at affordable prices
Marks the World Head & Neck Cancer Day at the OCTF Conference
Uses a simple mechanical approach for removing intrauterine tissues
Approval to dramatically change CAR-T therapies landscape
Rapid card test kits for iScreen malaria card antigen (Pf/Pv) & iScreen dengue NS1
Granules India sponsored an initiative to ignite a drug-free revolution and contribute towards an empowered society
Subscribe To Our Newsletter & Stay Updated